The anti-CD8 antibody can deplete mitotic SENP3 activation-mediated anti-tumor effect, suggesting that CD8+ T cells play a critical role in mitotic SENP3 activation-associated anti-tumor immunity. This evidence concerns the gene CD8A and neoplasm.